-+ 0.00%
-+ 0.00%
-+ 0.00%

Alzamend Neuro launches Phase II AL001 trial in bipolar disorder type 1 patients at Massachusetts General Hospital

Reuters·03/16/2026 12:01:51

Please log in to view news